Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Bruce Zuraw, William R. Lumry, Douglas T. Johnston, Emel Aygören-Pürsün, Aleena Banerji, Jonathan A. Bernstein, Sandra C. Christiansen, Joshua S. Jacobs, Karl V. Sitz, Richard G. Gower, Remi Gagnon, H. James Wedner, Tamar Kinaciyan, Roman Hakl, Jana Hanzlíková, John T. Anderson, Donald L. McNeil, Stephen B. Fritz, William H. Yang, Raffi TachdjianPaula J. Busse, Timothy J. Craig, H. Henry Li, Henriette Farkas, Jessica M. Best, Desiree Clemons, Melanie Cornpropst, Sylvia M. Dobo, Heather A. Iocca, Deborah Kargl, Eniko Nagy, Sharon C. Murray, Phil Collis, William P. Sheridan, Marcus Maurer, Marc A. Riedl

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint

Dive into the research topics of 'Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences